Tagged with BI

Colombia Ana Claudia Alvarez, the recently appointed Country Manager for GE Healthcare Colombia, discusses the company’s transition from hardware-based activities to advisory services, the relationship between medical equipment presence and cost reductions in the system, and the advantages of using powerful information systems in hospitals. She reveals her priority of implementing…

Hong Kong In 2017, Hong Kong fended off perennial competitors, life sciences hubs and innovation powerhouses, Switzerland and Singapore, to rank first in the International Institute for Management Development (IMD)’s World Competitiveness Rankings, clear evidence that conditions are ripe in Hong Kong to develop the first biotech unicorn – a start-up company…

Ukraine Victoria Bandyk, chief operating officer of the Bioscience Group, provides insights into the unique added value and the international development of this comprehensive group of companies, which aims to support local and international companies in positioning, registering, and promoting medicines across targeted European and Asian markets, finding strategic partners across…

Hong Kong Described as the first unicorn [a startup company valued at over USD 1 billion] of Hong Kong, Cirina has recently merged with Grail to further improve detection of cancer at its early stage. Pharmaboardroom sat down with Professor Denis Lo, the man behind Cirina’s technology, to further discuss his groundbreaking…

Hong Kong Professor Cheng, managing director of the Hong Kong Institute of Biotechnology, introduces the organization’s mission to improve development of biotechnology and traditional Chinese medicine sectors as well as the main challenges ahead. What is the mandate of the Hong Kong Institute of Biotechnology (HKIB)? “Our mission statement was – and…

Hong Kong Alexandre de Muralt, the man behind Merck’s operations in Hong Kong and Taiwan discusses the nuances of these two local markets. In addition, he shares his insights on how Merck’s transformation has impacted local affiliates. Can you begin by telling us about Merck’s strategic transformation in recent years? “Founded in…

Colombia David Torres, general manager of NAOS Colombia, one of the country’s most innovative firms, discusses the inherent challenges in the skincare industry and the specificities of the Colombian market, while highlighting the importance of institutional collaboration to raise skin-related issues and the affiliate’s priorities to further expand its footprint in…

Indonesia Milan Paleja, country president and general manager of Novartis Indonesia, discusses his main priorities since assuming his current position and the organization’s business expansion strategy, based on enhancing patient access to innovative medicines in both the public and private sectors. Mr. Paleja, you were appointed as country president and general…

Japan Kenichi Tamiya, director for Biomedical Policy at the Kobe City Government and managing director of the Kobe Foundation for Biomedical Research and Innovation (FBRI), discusses the central Japanese city of Kobe’s significant potential as a cutting-edge R&D hub for both the national and global life science industries. “Alongside promoting translational…

Colombia Rafael Salamanca, the founder of Depósito de Drogas Boyacá, shares his insights on the recent developments of the company in the challenging Colombian logistics environment, while revealing the essence of the company’s success relying on the combination of key factors: product, amount, customer, place and time. You’ve been in the…

Colombia Eduardo Franky Pardo, General Manager of Zambon Colombia, reveals exciting plans on launching the new promising medicine in the recently entered central nervous system therapeutic area, while continuously building their well- reputable presence in Colombia through their philosophy of making quality accessible to everyone. Could you introduce yourself to our…

Colombia Claudio Ferrari, General Manager of Scandinavia Pharma, proudly presents some of the latest product launches of the company and shares insights into the strategic role Scandinavia Pharma plays for Mega Pharma, as an ambitious player aiming to figure amongst the top five companies in the Colombian trade market by 2021.…